CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days

Bundibugyo Ebola AntigensPositive
AI Analysis

Summary

Dyadic announced the development of stable C1 cell lines capable of producing purified Scripps-designed Bundibugyo Ebola antigens from plasmids in approximately 15 days. This demonstrates Dyadic's production capabilities for rapid antigen manufacturing.

Importance:5/10
Sentiment:
0.60
cell line developmentEbola antigensproduction capabilityBundibugyoplasmid production
Related Companies

Read the original article

Published by yahoo_finance on July 28, 2026 12:30 PM

Read Original